Tata Memorial Centre-led project aims to slash cancer drug costs by up to 99 percent
Advertisement
A groundbreaking pilot initiative in India, led by the prestigious Tata Memorial Centre, a leading cancer hospital, has shown remarkable cost savings (averaging 82 percent) through the "pooled purchasing" of essential oncology and supportive-care medications. A study detailing the feasibility of this pooled procurement method, which involves group negotiations and agreement on pricing, was published in a World Health Organization (WHO) bulletin in June. The authors of the study include doctors from Tata Memorial Centre, including Director C.S. Pramesh, as well as professionals from the Jawaharlal Institute of Postgraduate Medical Education and Research in Puducherry and the Zulekha Yenepoya Institute of Oncology in Yenepoya, among others.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.